Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

ARHGEF11 USP53 TTK PKP4 PHF8

4.25e-0585317528718761
Pubmed

Establishment and Dysfunction of the Blood-Brain Barrier.

AVPR1A SLC16A7

2.94e-045217226590417
Pubmed

Protein array based interactome analysis of amyloid-β indicates an inhibition of protein translation.

ZC3H3 RSL1D1 PHF8

4.15e-0430517321244100
InteractionNOP14 interactions

USP53 ZC3H3 RSL1D1 ISG20L2

3.05e-05222174int:NOP14
InteractionRHOB interactions

ARHGEF11 TTK SLC16A7 RSL1D1 MAP4K5 PKP4

4.29e-05840176int:RHOB
CytobandEnsembl 112 genes in cytogenetic band chr12q14

AVPR1A SLC16A7

8.25e-04115172chr12q14
CytobandEnsembl 112 genes in cytogenetic band chr1q23

ARHGEF11 ISG20L2

3.13e-03226172chr1q23
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

USP53 SLC16A7 PKP4

3.06e-05163173cab65dabeea58141c649e4fec5e0123beb3de1b3
ToppCellLPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ZC3H3 TTK ZNF397

3.91e-05177173164ffbbf798defa3728197deb1a14b661490e525
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

USP53 SLC16A7 PKP4

3.97e-051781734df6218b20c2f076c22346d23260964cc0d73e65
ToppCelldroplet-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP53 AVPR1A SLC16A7

4.83e-05190173c408d4033a130c0168159a5b6f286fd2b2a9a39d
ToppCelldroplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

USP53 AVPR1A SLC16A7

4.83e-05190173d4910c37045a8b8bb53b37625263bc0a47b6e3f8
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

USP53 SLC16A7 PKP4

5.21e-051951733123e02d2894c83962ba402085b5e6422ebf8c73
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

USP53 SLC16A7 PKP4

5.29e-05196173e02301642243df483fd066d978317c113c04692b
ToppCellkidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

USP53 SLC16A7 PKP4

5.29e-051961731bfc3c85ce9501f52a912e53cbded7de74572b9d
DrugGlipizide [29094-61-9]; Down 200; 9uM; HL60; HG-U133A

SLC16A7 MAP4K5 PKP4 PHF8

1.21e-051981742008_DN
DrugImipenem [74431-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

ZC3H3 SLC16A7 MAP4K5

3.68e-041921732873_DN
DrugAmbroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A

ARHGEF11 ZC3H3 SLC16A7

3.68e-041921731623_DN
Drugchlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A

ARHGEF11 ASB13 PHF8

3.79e-041941731217_DN
DrugLoperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; PC3; HG-U133A

ZC3H3 ASB13 ISG20L2

3.85e-041951731949_DN
Drug(-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A

ARHGEF11 PKP4 PHF8

3.85e-041951733571_DN
Drug17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A

ARHGEF11 SLC16A7 ASB13

3.85e-041951736172_DN
DrugScopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A

SLC16A7 ASB13 PKP4

3.91e-041961736335_DN
Drughaloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA

ARHGEF11 MAP4K5 PHF8

3.91e-041961731041_UP
DrugSulfaguanidine [57-67-0]; Up 200; 18.6uM; PC3; HG-U133A

ARHGEF11 SLC16A7 PHF8

3.91e-041961731913_UP
DrugCephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A

ARHGEF11 MAP4K5 PKP4

3.91e-041961734826_DN
DrugAsiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A

ARHGEF11 USP53 PHF8

3.91e-041961732943_UP
DrugTocainide hydrochloride; Down 200; 17.4uM; HL60; HT_HG-U133A

SLC16A7 PKP4 PHF8

3.97e-041971732931_DN
DrugIfenprodil tartrate [23210-58-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A

ZC3H3 SLC16A7 PKP4

3.97e-041971735463_DN
DrugSulmazole [73384-60-8]; Up 200; 14uM; PC3; HT_HG-U133A

AVPR1A SLC16A7 PKP4

3.97e-041971734009_UP
DrugBuspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A

ARHGEF11 ZC3H3 SLC16A7

3.97e-041971735343_DN
DrugSulfameter [651-06-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A

SLC16A7 MAP4K5 PKP4

3.97e-041971736212_DN
Drug3-hydroxy-(D/L)-kynurenine; Up 200; 9.2uM; MCF7; HT_HG-U133A_EA

ARHGEF11 SLC16A7 PHF8

3.97e-041971731109_UP
Drugestradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A

MAP4K5 PKP4 PHF8

4.03e-041981736928_DN
DrugEstradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A

ARHGEF11 SLC16A7 ASB13

4.03e-041981731299_DN
DrugAcenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A

ASB13 MAP4K5 PHF8

4.03e-041981735878_DN
DrugCarbarsone [121-59-5]; Down 200; 15.4uM; HL60; HT_HG-U133A

ZC3H3 SLC16A7 MAP4K5

4.03e-041981731313_DN
DrugChlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; HL60; HT_HG-U133A

SLC16A7 ASB13 PHF8

4.03e-041981731272_DN
DrugTropine [120-29-6]; Down 200; 28.4uM; MCF7; HT_HG-U133A

ARHGEF11 ZC3H3 MAP4K5

4.03e-041981736264_DN
DrugNeomycin sulfate [1405-10-3]; Down 200; 4.2uM; HL60; HG-U133A

ARHGEF11 ASB13 MAP4K5

4.09e-041991731383_DN
DrugCiprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A

ZC3H3 SLC16A7 PHF8

4.15e-042001735299_DN
DrugAcetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A

ARHGEF11 ASB13 PKP4

4.15e-042001732061_DN
DrugNM-3

AVPR1A RSL1D1

7.34e-0454172CID005493470
Diseasealanine measurement

SLC16A7 MAP4K5

9.81e-0486162EFO_0009765
Diseaseglucose measurement

FOLH1 MAP4K5 ISG20L2

1.05e-03380163EFO_0004468
Diseaseglutamine measurement

SLC16A7 MAP4K5

1.25e-0397162EFO_0009768

Protein segments in the cluster

PeptideGeneStartEntry
SPSKDSEPSCWGKKK

PKP4

776

Q99569
KKPSDYTWSSSAPAK

ASB13

216

Q8WXK3
DKWLPFFPKTKKSSN

ARHGEF11

506

O15085
KSLYESWTKKSPSPE

FOLH1

491

Q04609
TVDGTWKTPSFPKKK

ISG20L2

66

Q9H9L3
WKTPSFPKKKTAASS

ISG20L2

71

Q9H9L3
DDSSPKKIKTKKSTW

SLC16A7

216

O60669
FGKPKTTNKKPSIWS

CCDC174

41

Q6PII3
QPPKLKDKTKWSSTF

MAP4K5

236

Q9Y4K4
SGDPSSKSTKIKWKS

SETSIP

171

P0DME0
KPKSSKDPSFSNWPK

USP53

616

Q70EK8
TSSKPGSAPSKYKWK

ZC3H3

366

Q8IXZ2
PSKSVRKASHTPKKW

RSL1D1

466

O76021
KTKSSGWIKLPSFKS

THEM5

76

Q8N1Q8
WKDSPKSSKSIKFIP

AVPR1A

401

P37288
TSKWFDPKSICKTPS

TTK

441

P33981
KTQLKSWKPCLSPKS

ZNF397

171

Q8NF99
SRPKKKKNSDDAPWS

PHF8

866

Q9UPP1